Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Trade Show, Webcast

Seattle Genetics Announces Cancellation of Presentation and Webcast at the Cowen 40th Annual Healthcare Conference


Seattle Genetics, Inc. (Nasdaq:SGEN) announced today the cancellation of the Company's presentation and webcast at the Cowen 40th Annual Healthcare Conference on Tuesday, previously scheduled to take place on March 3, 2020 at 9:20 a.m. Eastern Time. Management will no longer be attending the conference as a precautionary measure related to travel amidst the evolving coronavirus situation.

About Seattle Genetics

Seattle Genetics, Inc. is a global biotechnology company that discovers, develops and commercializes transformative medicines targeting cancer to make a meaningful difference in people's lives. ADCETRIS® (brentuximab vedotin) and PADCEVtm (enfortumab vedotin-ejfv) use the company's industry-leading antibody-drug conjugate (ADC) technology. ADCETRIS is approved in certain CD30-expressing lymphomas, and PADCEV is approved in certain metastatic urothelial cancers. In addition, investigational agent tucatinib, a small molecule tyrosine kinase inhibitor, is in late-stage development for HER2-positive metastatic breast cancer and in clinical development for metastatic colorectal cancer. The company is headquartered in Bothell, Washington, and has offices in California, Switzerland and the European Union. For more information on our robust pipeline, visit www.seattlegenetics.com and follow @SeattleGenetics on Twitter.


These press releases may also interest you

at 08:10
Skyflow, the data privacy vault company, has raised $30 million to extend its Series B funding. Khosla Ventures led the round, joined by prior investors Mouro Capital, Foundation Capital and Canvas Ventures. The investment follows revenue growth of...

at 08:10
NICE today announced that Triple Impact Connections, a veteran-owned BPO firm based in the United States, has selected the industry-leading NICE CXone platform to help drive great customer service and long-term value. With the move to CXone, Triple...

at 08:10
Edgewise Therapeutics, Inc. , a leading muscle disease biopharmaceutical company, today announced that the Company will present data on EDG-7500 at the American College of Cardiology's Annual Scientific Session (ACC.24). EDG-7500 is a first-in-class...

at 08:10
The Board of MariaDB plc ("MariaDB" or the "Company") confirms that on March 26, 2024, it received an unsolicited non-binding indicative proposal from Progress Software Corp. ("Progress") to acquire the entire issued and to be issued share capital...

at 08:08
B&H is ready for the 2024 Great North American Solar Eclipse and has all the resources and equipment you need to get ready yourself. Less than a month away, the total solar eclipse is happening on Monday, April 8, 2024, and starts at 11:07AM PT. This...

at 08:07
Input 1, a leading digital billing and payment solution provider to the insurance industry, is thrilled to announce two new features designed to enhance the capabilities and services of their platform. These additions, Custom Credit Card Statement...



News published on and distributed by: